Skip to main content

Table 4 OSNA accuracy compared with histopathological examination in included tumours

From: Application of One-Step Nucleic Acid Amplification (OSNA) in different cancer entities and usefulness in prostate cancer: a systematic review

Group

Author

H&E positive

H&E negative

Sensitivity

Specificity

Concordance

OSNA negative

OSNA positive

OSNA negative

OSNA positive

1)

Tsujimoto et al. [15]

0.6 (2)

13.2 (43)

85 (276)

1.2 (4)

95.6

98.6

98.2 (319/325)

Feldman et al. [28]

3 (31)

10.2 (107)

83.1 (868)

3.6 (38)

77.5

95.8

93.4 (975/1044)

Le Frère-Belda et al. [29]

2.4 (12)

10.1 (51)

82.1 (413)

5.4 (27)

80.9

93.9

92.2 (464/503)

Vegué et al. [30]

0 (0)

1.1 (6)

92.1 (522)

6.9 (39)

100

93

93.1 (528/567)

Wang et al. [31]

2.6 (31)

13.4 (159)

78 (927)

6 (71)

83.7

92.9

91.4 (1086/1188)

Pathmanathan et al. [32]

1.8 (3)

14.7 (25)

80.6 (137)

3 (5)

89.3

96.5

95.3 (162/170)

Banerjee et al. [33]

0.7 (2)

14.6 (39)

81 (217)

3.7 (10)

95.1

95.6

95.5 (256/268)

Li et al. [34]

2 (6)

9.6 (30)

85.5 (266)

2.9 (9)

83.3

96.7

95.2 (296/311)

2)

Croner et al. [35]

1.6 (3)

20.1 (37)

75.5 (139)

2.7 (5)

92.5

96.5

95.7 (176/184)

Yamamoto et al. [36]

1 (4)

20.5 (79)

76.6 (295)

1.8 (7)

95.2

97.7

97.1 (374/385)

Guller et al. [37]

0.6 (2)

16.3 (51)

79.6 (249)

3.5 (11)

96.2

95.7

95.8 (300/313)

Yamamoto et al. [38]

1 (20)

6.5 (125)

89.2 (1717)

3.3 (63)

86.2

96.5

95.7 (1842/1925)

Yaguchi et al. [39]

3.1 (5)

24.7 (40)

69.8 (113)

2.5 (4)

88.9

96.6

94.4 (153/162)

Kumagai et al. [40]

2.3 (9)

11.4 (45)

82.7 (326)

3.6 (14)

83.3

95.9

94.2 (371/394)

Shimada et al. [41]

1.8 (8)

3.2 (14)

93.9 (412)

1.1 (5)

63.6

98.8

97 (426/439)

3)

Okamoto et al. [42]

2.3 (3)

2.3 (3)

93.8 (122)

1.5 (2)

50

98.4

96.2 (125/130)

Nagai et al. [43]

2.2(3)

10.2 (14)

86.9 (119)

0.7 (1)

82.4

99.2

97.1 (133/137)

Fanfani et al. [44]

0.9 (1)

7.2 (8)

86.4 (95)

5.4 (6)

88.9

94.1

93.6 (103/110)

Kost’un et al. [45]

0.7 (1)

7.4 (10)

78.5 (106)

13.3 (18)

90.9

85.5

85.9 (116/135)

4)

Inoue et al. [46]

0.6 (1)

11.5 (19)

87.3 (144)

0.6 (1)

95

99.3

98.8 (163/165)

Nakagawa et al. [47]

2.9 (12)

11.5 (47)

81.2 (333)

4.4 (18)

79.7

94.5

92.7 (380/410)

Escalante-Pérez et al. [48]

0.1 (1)

4.8 (34)

91.3 (644)

3.7 (26)

97.1

96.1

96.2 (678/705)

5)

Goda et al. [49]

2.6 (8)

17 (53)

77.2 (241)

3.2 (10)

86.9

96

94.2 (294/312)

Sofía del Carmen et al. [50]

5.2 (14)

28.1 (75)

60 (160)

6.7 (18)

84.2

89.9

88 (235/267)

6)

Engels et al. [24]

2.2 (12)

14.2 (76)

80.5 (452)

3.4 (18)

91.4

100

98.8 (528/534)

  1. Figures are expressed as percentages and (number of cases) in parentheses
  2. H&E Hematoxylin and eosin, No Number of, OSNA One-step nucleic acid amplification